Navigation Links
Team discovers new inhibitors of estrogen-dependent breast cancer cells
Date:6/16/2008

Researchers have discovered a new family of agents that inhibit the growth of estrogen-dependent breast cancer cells. The finding, described today at a meeting of the Endocrine Society, has opened an avenue of research into new drugs to combat estrogen-dependent breast cancers.

"This cell-based study is exciting because it suggests these compounds are likely to be effective in tumors that remain dependent on estrogen for growth but are resistant to current therapies," said principal investigator David J. Shapiro, a professor of biochemistry in the School of Molecular and Cellular Biology at the University of Illinois.

Although multiple factors contribute to the development of breast cancer, estrogens play a key role in the growth of many tumors. More than 80 percent of breast cancer tumors in women over age 45 are activated by estrogen by way of a protein called an estrogen receptor. When estrogen binds to the receptor, this "estrogen-receptor complex" latches on to DNA and prompts it to transcribe the RNA blueprints for new proteins that promote cell growth, migration and division.

Current therapies for estrogen-receptor-positive (ER-positive) breast cancers include the use of drugs, such as tamoxifen, that interfere with estrogen's ability to bind to the estrogen receptor. Over time, however, ER-positive breast cancer tumors become resistant to tamoxifen. In some resistant tumors, tamoxifen even begins to act like estrogen and actually stimulates tumor growth.

"Tamoxifen is useful in that it is very effective at blocking recurrence of breast cancer in patients for whom the entire tumor is removed," Shapiro said. "But for patients who still have existing tumors, eventually those tumors will become resistant."

Shapiro's team sought to target other steps in the pathway of estrogen action. Using a technique they developed that can quickly determine whether the target DNA is or is not bound by the estrogen-receptor complex, the team was able to screen a long list of potential therapeutic compounds to see if they inhibited the binding of the complex to the DNA. They then tested these agents in ER-positive breast cancer cells.

The team identified several compounds that reduce the binding of estrogen-receptor complex to the regulatory regions of genes that are normally activated by this complex. These agents effectively retarded production of the proteins that promote the growth and proliferation of ER-positive breast cancer cells.

"These small molecules specifically block growth of estrogen-dependent breast cancer cells with little or no effect on other cells," Shapiro said. "This work sets the stage for further development and testing of these inhibitors."


'/>"/>

Contact: Diana Yates
diya@illinois.edu
217-333-5802
University of Illinois at Urbana-Champaign
Source:Eurekalert

Related medicine news :

1. OHSU Cancer Institute researcher discovers what fuels certain cancer mutation
2. Research discovers new compounds active against tuberculosis and malaria
3. OHSU cancer institute researcher discovers new predictor of prostate cancer recurrence
4. NYU dental professor discovers biological clock
5. U of Minnesota researcher discovers the starting point of sun-induced skin cancer
6. Silencing small but mighty cancer inhibitors
7. Effect of tumor necrosis factor a inhibitors on heart failure risk in RA Patients
8. NSAIDs: Painkillers, inflammation inhibitors, anti-cancer drugs and new de-methylating agents
9. Gastric juice for diagnosis of H. pylori infection in patients on proton pump inhibitors
10. FDA Approves NOVO NORDISKs NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors
11. Survival differences by race most apparent in advanced stages of breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... , ... January 17, 2017 , ... ... supplement, Healthful-Flex. , The company, owned and operated by Ed Stroup, was ... a reasonable price with the highest level of customer service. Healthful Balance products ...
(Date:1/17/2017)... ... 17, 2017 , ... Metro Development Group has broken ground ... technology into the fabric of an entire community. A highlight of this new ... in a yet-to-be-named, health focused campus. Leading this initiative in partnership with Metro ...
(Date:1/17/2017)... ... January 17, 2017 , ... Peoples Health ... Peoples Health network on Dec. 1, 2016. Peoples Health, a Metairie-based Medicare Advantage ... is an exciting addition to our provider network, and the addition will benefit ...
(Date:1/17/2017)... ... , ... Neil H. Greco Insurance Agency, a northern New Jersey firm that ... launching a charity drive to raise awareness of heart disease and promote habits that ... and is responsible for 1 in every 4 deaths at the national level each ...
(Date:1/17/2017)... Westford, Mass. (PRWEB) , ... January 17, 2017 ... ... management company to visualize, detect, and eliminate cyber threats in real-time, today announced ... and Solutions provider, headquartered in Selangor, Malaysia. Joining other Seceon partners, TechLab Security ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... PUNE, India , Jan. 17, 2017  Market Research Future ... Global Endoscopy Devices Market is expected to reach USD 33.6 million ... 2016. Market Highlights ... The Global Endoscopy Devices Market has been examined as ... rate. Globally there is huge demand for endoscopy device in various ...
(Date:1/17/2017)... Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential ... or the "Company") (NASDAQ: ANTH ). Such investors ... by visiting the firm,s site: www.bgandg.com/anth .   ... and/or directors have violated Sections 10(b) and 20(a) of the ... ...
(Date:1/17/2017)... 2017  In a letter to President-elect Donald ... outlines AARP,s priorities for Americans age 50 and ... to affordable health care coverage, and lowering the cost ... writes to President-elect Trump that "Our nearly 38 million ... you to protect their Medicare and Social Security benefits, ...
Breaking Medicine Technology: